Michele W. Sartori
Clients rely on Michele Sartori's resolve in handling white collar criminal defense, government investigations, internal investigations, government enforcement actions, and complex civil litigation — particularly qui tam litigation.
Practice Area Leader for the firm's Investigations, White Collar and Fraud Practice Group, Michele has notable experience in pharmaceutical, medical device, and healthcare fraud investigations, as well as False Claims Act litigation.
She also represents government contractors, financial institutions, educational institutions, and technology companies in criminal and civil investigations. Michele has handled FCPA investigations, data breach investigations, and various other criminal investigations at federal, administrative, and state levels throughout the U.S.
Prior to joining the firm, Michele served as an Assistant U.S. Attorney for the District of Maryland. As a federal prosecutor, she investigated and prosecuted a wide range of cases in federal court, including complex financial fraud, healthcare fraud, cyber crimes, tax crimes, government fraud, and public corruption. Michele conducted complex grand jury investigations, tried a dozen cases to jury verdict, and argued in the U.S. Court of Appeals for the Fourth Circuit.
During her tenure as an Assistant U.S. Attorney, Michele worked closely with trial attorneys at the Department of Justice, as well as with investigators and attorneys from a wide range of government agencies, including the Food and Drug Administration.
Prior to joining the U.S. Department of Justice, Michele practiced complex civil litigation at Hogan Lovells. Before that, Michele served as a judicial clerk to The Honorable Marvin J. Garbis of the U.S. District Court for the District of Maryland.
Represents pharmaceutical and biologics companies in connection with investigations of sales and marketing, pricing, and kickback allegations.
Represents pharmaceutical and medical device manufacturers in investigations of alleged violations of the FDCA due to cGMP non-compliance.
Represented major orthopedic device company in connection with a criminal and civil investigation of sales and marketing and billing practices.
Represent medical device companies in defending False Claims Act matters arising from reimbursement, FDCA promotional, and fraud and abuse theories.
Represents drug and biologics manufacturers in defending False Claims Act matters based on government price reporting allegations.
Represent universities, academic health centers, and hospitals in connection with False Claims Act investigations and litigation.